Venrock Healthcare Capital Partners XP, L.P. Insider Trading -- Recent SEC Form 4 Transactions
Venrock Healthcare Capital Partners XP, L.P. (CIK 2037157) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-04). Recent activity: Buy LYCA (8,305 shares), Buy LYCA (10,570 shares), Buy LYCA (4,430 shares), Buy LYCA (1,000 shares), Buy LYCA (8,804 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-04 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 8,305 | $223,820 |
| 2026-10-30 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 10,570 | $266,681 |
| 2026-10-30 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 4,430 | $115,047 |
| 2026-10-30 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 1,000 | $26,330 |
| 2026-10-30 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 8,804 | $231,281 |
| 2026-10-30 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 200 | $5,372 |
| 2026-10-27 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 24,560 | $630,701 |
| 2026-10-27 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 28,379 | $740,976 |
| 2026-10-27 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 4.8M | $0 |
| 2026-10-27 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 1.9M | $35.0M |
| 2026-10-27 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 8,261 | $222,799 |
| 2026-10-27 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 8,729 | $225,557 |
| 2026-10-27 | Lycia Therapeutics, Inc. (LYCA) | 10% Owner | Buy | 31,067 | $833,838 |
Source: SEC Form 4 filings · as of 2026-11-04